Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly

Aagaard, 2007, RNAi therapeutics: principles, prospects and challenges, Adv Drug Deliv Rev, 59, 75, 10.1016/j.addr.2007.03.005 Huang, 2008, Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications, Expert Opin Ther Targets, 12, 637, 10.1517/14728222.12.5.637 Shapira, 2011, Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance, Drug Resist Updat, 14, 150, 10.1016/j.drup.2011.01.003 Ryan, 2009, Survivin: a new target for anti-cancer therapy, Cancer Treat Rev, 35, 553, 10.1016/j.ctrv.2009.05.003 Pennati, 2008, Targeting survivin in cancer therapy, Expert Opin Ther Targets, 12, 463, 10.1517/14728222.12.4.463 Xu, 2010, The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model, Biomaterials, 31, 916, 10.1016/j.biomaterials.2009.09.103 Xue, 2011, Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization, Biomaterials, 32, 2662, 10.1016/j.biomaterials.2010.12.029 Wani, 1971, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J Am Chem Soc, 93, 2325, 10.1021/ja00738a045 Schiff, 1980, Taxol stabilizes microtubules in mouse fibroblast cells, Proc Natl Acad Sci USA, 77, 1561, 10.1073/pnas.77.3.1561 Singla, 2002, Paclitaxel and its formulations, Int J Pharm, 235, 179, 10.1016/S0378-5173(01)00986-3 Luo, 2012, Advances of paclitaxel formulations based on nanosystem delivery technology, Mini Rev Med Chem, 12, 434, 10.2174/138955712800493924 Heo, 2012, Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy, Biomaterials, 33, 856, 10.1016/j.biomaterials.2011.09.064 Zhang, 2011, Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates, ACS Nano, 5, 6962, 10.1021/nn201446c Yao, 2011, The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery, Biomaterials, 32, 3285, 10.1016/j.biomaterials.2011.01.038 Wang, 2011, A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model, ACS Nano, 5, 6184, 10.1021/nn200739q Chen, 2010, Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer, J Biol Chem, 285, 22639, 10.1074/jbc.M110.125906 Chen, 2009, Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells, Small, 5, 2673, 10.1002/smll.200900621 Sun, 2011, Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression, ACS Nano, 5, 1483, 10.1021/nn103349h Xiong, 2011, Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin, ACS Nano, 5, 5202, 10.1021/nn2013707 Huang, 2011, Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression, J Biomed Mater Res A, 97, 330, 10.1002/jbm.a.33055 Hu, 2011, Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug, Chem Commun (Camb), 47, 5572, 10.1039/c1cc10721f Fan, 2012, In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL, Biomaterials, 33, 1428, 10.1016/j.biomaterials.2011.10.043 Chen, 2011, Cyclodextrin-based inclusion complexation bridging supramolecular chemistry and macromolecular self-assembly, Chem Soc Rev, 40, 2254, 10.1039/c0cs00153h Tang, 2006, Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system, J Gene Med, 8, 736, 10.1002/jgm.874 Lin, 2008, Effect of chemical functionalities in poly(amido amine)s for non-viral gene transfection, J Control Release, 132, 267, 10.1016/j.jconrel.2008.06.022 Brummelkamp, 2002, A system for stable expression of short interfering RNAs in mammalian cells, Science, 296, 550, 10.1126/science.1068999 Kim, 2010, Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex, Biomaterials, 31, 4592, 10.1016/j.biomaterials.2010.02.030 Ikeguchi, 2002, Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma, Diagn Mol Pathol, 11, 33, 10.1097/00019606-200203000-00007 Rosa, 2006, Survivin modulates microtubule dynamics and nucleation throughout the cell cycle, Mol Biol Cell, 17, 1483, 10.1091/mbc.E05-08-0723 Chen, 2012, Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells, Mol Med Rep, 5, 917, 10.3892/mmr.2012.755